BCRX BioCryst Pharmaceuticals, Inc. logo

BCRX BioCryst Pharmaceuticals, Inc.

Healthcare
$8.47+2.17%ClosedMarket Cap: $1.78B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

289

13F Shares

208,553,474

Ownership %

99.2%

New Positions

49

Increased Positions

141

Closed Positions

62

Reduced Positions

100

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
GERMETFMG Treatments, Testing and Advancements ETF45,4263.70%
PBEInvesco Biotechnology & Genome ETF923,4583.65%
VALT53,3402.65%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF60,4502.47%
BBPVirtus Biotech ETF111,5292.07%
XBI6,655,0540.91%
LABUDirexion Daily S&P Biotech Bull 3X ETF333,3150.64%
ASQCX103,0580.51%
VMNFX222,4440.46%
VSTCX954,8820.32%
BFORBarron's 400SM ETF60,2500.29%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF211,2480.24%
ISMDInspire Small/Mid Cap ETF64,0090.23%
FLQSFranklin U.S. Small Cap Multifactor Index ETF11,1540.23%
PSCPrincipal U.S. Small-Cap Multi-Factor ETF413,9980.22%
IBBiShares Biotechnology ETF1,715,8260.21%
VSEQX2,570,9540.20%
SMLFiShares U.S. Small-Cap Equity Factor ETF677,4280.20%
IBBQInvesco Nasdaq Biotechnology ETF14,7490.20%
BIBProShares - Ultra Nasdaq Biotechnology11,2200.14%